Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

TERNARY COMPLEX THERAPY FOR AUTOIMMUNE-DISEASE HOSPITAL PRACTICE Fathman, C. G. 1995; 30 (8): 57-?

Abstract

Induction of an immune response is remarkably simple, involving the interaction of three components: processed antigen, an MHC class II molecule, and a CD4 T-cell receptor. Each part of this ternary complex represents a novel target for interventions that may block subsequent effector phenomena of autoimmune disease. Such specific treatments will be less toxic than those currently available.

View details for Web of Science ID A1995RN91300018

View details for PubMedID 7635912